Peter M. Hecht 13D and 13G filings for Cyclerion Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-05-12 08:39 am Purchase | 2023-05-11 | 13D | Cyclerion Therapeutics, Inc. CYCN | Peter M. Hecht | 518,465 19.990% | 307,482 (+145.74%) | Filing |
| 2023-04-03 07:30 am Purchase | 2023-03-31 | 13D | Cyclerion Therapeutics, Inc. CYCN | Peter M. Hecht | 210,983 9.200% | 980 (+0.47%) | Filing |
| 2022-11-21 5:00 pm Purchase | 2022-11-20 | 13D | Cyclerion Therapeutics, Inc. CYCN | Peter M. Hecht | 210,003 9.200% | 30,169 (+16.78%) | Filing |
| 2021-06-07 5:21 pm Purchase | 2021-06-03 | 13D | Cyclerion Therapeutics, Inc. CYCN | Peter M. Hecht | 179,833 8.600% | 41,159 (+29.68%) | Filing |
| 2021-05-14 4:56 pm Purchase | 2021-05-04 | 13D | Cyclerion Therapeutics, Inc. CYCN | Peter M. Hecht | 138,675 7.800% | 138,675 (New Position) | Filing |